These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12520253)

  • 1. Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss.
    de Hoog M; van Zanten BA; Hop WC; Overbosch E; Weisglas-Kuperus N; van den Anker JN
    J Pediatr; 2003 Jan; 142(1):41-6. PubMed ID: 12520253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter evaluation of how many infants with permanent hearing loss pass a two-stage otoacoustic emissions/automated auditory brainstem response newborn hearing screening protocol.
    Johnson JL; White KR; Widen JE; Gravel JS; James M; Kennalley T; Maxon AB; Spivak L; Sullivan-Mahoney M; Vohr BR; Weirather Y; Holstrum J
    Pediatrics; 2005 Sep; 116(3):663-72. PubMed ID: 16140706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of hearing screening in high-risk neonates: comparative study of otoacoustic emission, automated and conventional auditory brainstem response.
    Suppiej A; Rizzardi E; Zanardo V; Franzoi M; Ermani M; Orzan E
    Clin Neurophysiol; 2007 Apr; 118(4):869-76. PubMed ID: 17317296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of hypoxia, premature birth, infection, ototoxic drugs, circulatory system and congenital disease on neonatal hearing loss.
    Yoshikawa S; Ikeda K; Kudo T; Kobayashi T
    Auris Nasus Larynx; 2004 Dec; 31(4):361-8. PubMed ID: 15571908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal newborn hearing screening: are we achieving the Joint Committee on Infant Hearing (JCIH) objectives?
    Connolly JL; Carron JD; Roark SD
    Laryngoscope; 2005 Feb; 115(2):232-6. PubMed ID: 15689741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of auditory brainstem responses and otoacoustic emissions in hearing screening of high-risk neonates].
    Xu FL; Xing QJ; Cheng XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):460-3. PubMed ID: 18706161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure.
    Robertson CM; Tyebkhan JM; Peliowski A; Etches PC; Cheung PY
    Acta Paediatr; 2006 Feb; 95(2):214-23. PubMed ID: 16449030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn hearing screening in the NICU: profile of failed auditory brainstem response/passed otoacoustic emission.
    Berg AL; Spitzer JB; Towers HM; Bartosiewicz C; Diamond BE
    Pediatrics; 2005 Oct; 116(4):933-8. PubMed ID: 16199704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk neonatal hearing screening program using automated screening device performed by trained nursing personnel at Siriraj Hospital: yield and feasibility.
    Srisuparp P; Gleebbur R; Ngerncham S; Chonpracha J; Singkampong J
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S176-82. PubMed ID: 16856439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hearing screening in the neonatal intensive care unit: follow-up of referrals.
    Lieu JE; Karzon RK; Mange CC
    Am J Audiol; 2006 Jun; 15(1):66-74. PubMed ID: 16803793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No hearing loss after repeated courses of tobramycin in cystic fibrosis patients.
    Scheenstra RJ; Heijerman HG; Zuur CL; Touw DJ; Rijntjes E
    Acta Otolaryngol; 2010 Feb; 130(2):253-8. PubMed ID: 19479457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients.
    Mulheran M; Hyman-Taylor P; Tan KH; Lewis S; Stableforth D; Knox A; Smyth A
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2293-9. PubMed ID: 16801404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The results of newborn hearing screening by means of transient evoked otoacoustic emissions.
    Wroblewska-Seniuk K; Chojnacka K; Pucher B; Szczapa J; Gadzinowski J; Grzegorowski M
    Int J Pediatr Otorhinolaryngol; 2005 Oct; 69(10):1351-7. PubMed ID: 15904979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of auditory neuropathy detected by universal newborn hearing screening program.
    Kirkim G; Serbetcioglu B; Erdag TK; Ceryan K
    Int J Pediatr Otorhinolaryngol; 2008 Oct; 72(10):1461-9. PubMed ID: 18674822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are gentamicin and/or vancomycin associated with ototoxicity in the neonate? A retrospective audit.
    Vella-Brincat JW; Begg EJ; Robertshawe BJ; Lynn AM; Borrie TL; Darlow BA
    Neonatology; 2011; 100(2):186-93. PubMed ID: 21455009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot case control follow-up study on hearing in children treated with tobramycin in the newborn period.
    de Hoog M; van Zanten GA; Hoeve LJ; Blom AM; van den Anker JN
    Int J Pediatr Otorhinolaryngol; 2002 Sep; 65(3):225-32. PubMed ID: 12242138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
    de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
    Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal newborn hearing screening in Mexico: results of the first 2 years.
    Yee-Arellano HM; Leal-Garza F; Pauli-Müller K
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1863-70. PubMed ID: 16914209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further examination of infants referred from newborn hearing screening.
    Wada T; Kubo T; Aiba T; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):17-25. PubMed ID: 15513505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.